33
Participants
Start Date
November 16, 2021
Primary Completion Date
December 1, 2026
Study Completion Date
October 1, 2028
Acalabrutinib
Dose per protocol, oral twice daily per cycle
Rituximab
Premedications (including acetaminophen, an antihistamine, and a steroid) will be given per institutional guideline Dosage determined per protocol and cycle timepoint, Route IV or SQ per protocol and cycle timepoint, schedule per protocol and cycle timepoint
RECRUITING
Massachusetts General Hospital, Boston
RECRUITING
Dana Farber Cancer Institute, Boston
Collaborators (1)
AstraZeneca
INDUSTRY
Shayna Sarosiek, MD
OTHER